Financial statements for year ended 31 July 2026

Company registration number: 15818025 (England & Wales)

MYCODISIACS LIMITED Unaudited financial statements For the year ended 31 July 2026

— 1 —


MYCODISIACS LIMITED		Company No. 15818025

Company information for the year ended 31 July 2026


Directors	Kian De La Cour

Company number	15818025 (England & Wales)

Registered office	116 The Street Rockland St. Mary Norwich NR14 7HQ

Accountant	Bloodwood Accounting Ltd
	50 Linden Road Birmingham B30 1JU

— 2 —


MYCODISIACS LIMITED		Company No. 15818025

Director's Report for the year ended 31 July 2026


The director presents their report and the financial statements for the year ended 31 July 2026.

Director

Kian De La Cour

Statement of directors' responsibilities

The director is responsible for preparing the report and accounts in accordance with applicable law and regulations. Company law requires the director to prepare accounts for each financial year. Under that law, the director has elected to prepare the accounts in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the accounts unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these accounts, the director is required to: • select suitable accounting policies and then apply them consistently; • make judgements and estimates that are reasonable and prudent; • prepare the accounts on the going concern basis unless it is inappropriate to presume that the company will continue in business. The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the accounts comply with the Companies Act 2006. They is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Signed by

_________________________________________________________

Kian De La Cour
Director

Approved on 3 August 2026

— 3 —


MYCODISIACS LIMITED	Company No. 15818025

Balance sheet as at 31 July 2026

			2026
		Note	£
Current assets
Cash at bank and in hand			(100)
			(100)
Net current liabilities			(100)
Total assets less current liabilities			(100)
Net liabilities			(100)
Capital and reserves
Called up share capital			(100)
Shareholders' funds			(100)

For the year ending 31 July 2026 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities.

These accounts were approved and signed by the director on 3 August 2026 __________________________________________________ Kian De La Cour

— 4 —


MYCODISIACS LIMITED		Company No. 15818025

Notes to the accounts


1 Average number of employees

The average number of employees during the year was: 0.

— 5 —